{"id":12833,"date":"2023-05-11T14:37:25","date_gmt":"2023-05-11T18:37:25","guid":{"rendered":"https:\/\/www.med.unc.edu\/genetics\/?p=12833"},"modified":"2023-05-11T14:39:06","modified_gmt":"2023-05-11T18:39:06","slug":"genetics-faculty-featured-at-unc-linebergers-46th-annual-scientific-symposium","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/genetics\/genetics-faculty-featured-at-unc-linebergers-46th-annual-scientific-symposium\/","title":{"rendered":"Genetics Faculty Featured at UNC Lineberger\u2019s 46th Annual Scientific Symposium"},"content":{"rendered":"

Leading investigators offer \u2018highly scientific, but patient-focused\u2019 talks on women\u2019s cancers at symposium<\/p>\n

UNC Lineberger\u2019s 46th<\/sup>\u00a0annual Scientific Symposium on April 24-25 brought together more than 350 people in person and virtually to hear talks on the latest research on women\u2019s cancers.<\/p>\n

\"Caption
UNC Lineberger\u2019s Vickie Bae-Jump, MD, PhD, Lisa Carey, MD, ScM, FASCO, and Chuck Perou, PhD, present at the UNC Lineberger Scientific Symposium.<\/figcaption><\/figure>\n

The day-and-a-half meeting was chaired by\u00a0Vickie Bae-Jump, MD, PhD<\/a>,\u00a0Lisa Carey, MD, ScM, FASCO<\/a>, and\u00a0Chuck Perou, PhD<\/a>, and featured 15 presentations on women\u2019s cancers, with a focus on breast, endometrial and ovarian cancers.<\/p>\n

\u201cThis is the first symposium that was designed around a cancer type itself, rather than biologic and preclinical processes,\u201d Carey said, adding that she, Bae-Jump and Perou were intentional in this approach to bring together research insights from the lab, the clinic and the community. \u201cThis made for a highly scientific, but patient-focused symposium.\u201d<\/p>\n

Perou said this approach made it possible to cover a broad range of disciplines and topics that were all relevant to women\u2019s health.<\/p>\n

\u201cThese topics ranged from molecular findings, to new possible biomarkers of treatment response, to new prevention strategies, to new clinical trials with exciting novel drugs,\u201d Perou said. \u201cWe all got exposed to a huge diversity of topics that made us all think deeply about what we heard, and which will certainly influence our future research.\u201d<\/p>\n